These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8128353)

  • 1. Prostacyclin production in acute, chronic, and long-term experimental portal hypertension.
    Sitzmann JV; Campbell K; Wu Y; St Clair C
    Surgery; 1994 Mar; 115(3):290-4. PubMed ID: 8128353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation.
    Hou MC; Cahill PA; Zhang S; Wang YN; Hendrickson RJ; Redmond EM; Sitzmann JV
    Hepatology; 1998 Jan; 27(1):20-7. PubMed ID: 9425912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of splanchnic vascular sensitivity to angiotensin II.
    Wu YP; Li SS; Campbell KA; Sitzmann JV
    Surgery; 1991 Aug; 110(2):162-8. PubMed ID: 1907031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension.
    Sitzmann JV; Bulkley GB; Mitchell MC; Campbell K
    Ann Surg; 1989 Mar; 209(3):322-7. PubMed ID: 2493776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for role of prostacyclin as a systemic hormone in portal hypertension.
    Sitzmann JV; Li SS; Adkinson NF
    Surgery; 1991 Feb; 109(2):149-53. PubMed ID: 1992548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
    Wu Y; Burns RC; Sitzmann JV
    Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal hemodynamics and humoral factors involved in a portal hypertensive rabbit model.
    Lin PW; Shan YS
    Proc Natl Sci Counc Repub China B; 1995 Oct; 19(4):240-5. PubMed ID: 8742622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of overproduction of plasma prostacyclin in portal hypertensive rats.
    Cao H; Wu Z; Zhou J; Jiao Z; Chen Z; Kuang Y
    Chin Med J (Engl); 1998 Dec; 111(12):1064-7. PubMed ID: 11263364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension.
    Sitzmann JV; Li SS; Lin PW
    J Surg Res; 1989 Sep; 47(3):208-11. PubMed ID: 2504995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal and splanchnic hemodynamic alterations following hepatic resection.
    Wu Y; Campbell KA; Sitzmann JV
    J Surg Res; 1993 Jul; 55(1):44-8. PubMed ID: 8412081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the development of portosystemic shunts in the maintenance of portal hypertension in rats].
    Braillon A; Koshy A; Lee SS; Girod C; Lebrec D
    Gastroenterol Clin Biol; 1988; 12(8-9):641-5. PubMed ID: 3215429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
    Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
    Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of cyclooxygenase 2 and prostaglandin I2 in the development of portal hypertensive gastropathy].
    Wu CX; Shi YJ; Liu CA; Gong JP; Li SW
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):536-8. PubMed ID: 14552713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
    Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
    Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics.
    Cahill PA; Hou MC; Hendrickson R; Wang YN; Zhang S; Redmond EM; Sitzman JV
    Hepatology; 1998 Aug; 28(2):396-403. PubMed ID: 9696003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.